GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PharmChem Inc (OTCPK:PCHM) » Definitions » Cyclically Adjusted Revenue per Share

PharmChem (PharmChem) Cyclically Adjusted Revenue per Share : $11.15 (As of Sep. 2023)


View and export this data going back to 2003. Start your Free Trial

What is PharmChem Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

PharmChem's adjusted revenue per share for the three months ended in Sep. 2023 was $0.311. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $11.15 for the trailing ten years ended in Sep. 2023.

During the past 12 months, PharmChem's average Cyclically Adjusted Revenue Growth Rate was 58.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 3.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of PharmChem was 5.80% per year. The lowest was 3.50% per year. And the median was 4.65% per year.

As of today (2024-06-07), PharmChem's current stock price is $3.11. PharmChem's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2023 was $11.15. PharmChem's Cyclically Adjusted PS Ratio of today is 0.28.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PharmChem was 0.32. The lowest was 0.18. And the median was 0.24.


PharmChem Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for PharmChem's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmChem Cyclically Adjusted Revenue per Share Chart

PharmChem Annual Data
Trend Dec93 Dec94 Dec95 Dec96 Dec97 Dec98 Dec99 Dec00 Dec01 Dec02
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.82 6.29 6.73 6.90 6.98

PharmChem Quarterly Data
Jun99 Sep99 Dec99 Mar00 Jun00 Sep00 Dec00 Mar01 Jun01 Sep01 Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Sep22 Sep23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.04 6.98 6.98 10.95 11.15

Competitive Comparison of PharmChem's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, PharmChem's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmChem's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PharmChem's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where PharmChem's Cyclically Adjusted PS Ratio falls into.



PharmChem Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PharmChem's adjusted Revenue per Share data for the three months ended in Sep. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=0.311/129.8595*129.8595
=0.311

Current CPI (Sep. 2023) = 129.8595.

PharmChem Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
199406 1.260 62.443 2.620
199409 1.483 63.034 3.055
199412 1.780 63.160 3.660
199503 1.760 63.877 3.578
199506 1.455 64.341 2.937
199509 1.545 64.637 3.104
199512 1.844 64.763 3.697
199603 1.485 65.692 2.936
199606 1.620 66.113 3.182
199609 1.590 66.578 3.101
199612 1.270 66.915 2.465
199703 1.593 67.506 3.064
199706 1.667 67.632 3.201
199709 1.714 68.012 3.273
199712 1.367 68.054 2.608
199803 1.425 68.434 2.704
199806 2.300 68.771 4.343
199809 2.260 69.025 4.252
199812 1.590 69.151 2.986
199903 1.700 69.615 3.171
199906 1.665 70.122 3.083
199909 1.934 70.839 3.545
199912 1.812 71.008 3.314
200003 1.719 72.231 3.090
200006 1.935 72.737 3.455
200009 1.972 73.286 3.494
200012 0.870 73.413 1.539
200103 1.648 74.341 2.879
200106 1.543 75.100 2.668
200109 1.678 75.227 2.897
200112 1.380 74.552 2.404
200203 1.275 75.438 2.195
200206 1.378 75.902 2.358
200209 1.250 76.366 2.126
200212 1.235 76.324 2.101
200303 1.082 77.716 1.808
200306 1.215 77.505 2.036
200309 1.172 78.138 1.948
202209 0.266 125.227 0.276
202309 0.311 129.860 0.311

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


PharmChem  (OTCPK:PCHM) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

PharmChem's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3.11/11.15
=0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PharmChem was 0.32. The lowest was 0.18. And the median was 0.24.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


PharmChem Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of PharmChem's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmChem (PharmChem) Business Description

Traded in Other Exchanges
N/A
Address
2411 E. Loop 820 N, Fort Worth, TX, USA, 76118
PharmChem Inc is engaged in selling and distributing of the PharmChek Sweat Patch Device. PharmChek is a system that uses sweat to detect the presence of illegal drugs. It consists of a transparent polyurethane outer covering, a small absorbent pad, and a release liner. Geographically the activities are carried out throughout the United States.
Executives
Alto Investors Palo 10 percent owner 470 UNIVERSITY AVENUE, PALO ALTO CA 94301
Micro Cap Partners Lp 10 percent owner

PharmChem (PharmChem) Headlines

From GuruFocus

PharmChem (PCHM) Announces Response To Opposition

By PRNewswire PRNewswire 08-11-2021